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The susceptibility of 18 antibiotics for transfer from goat milk to the resulting cheese 20 
whey was evaluated. Raw milk spiked with antibiotics was coagulated by rennet and 21 
the whey was separated. The antimicrobial activity of the whey, estimated by using 22 
microbial inhibitor tests, was applied as an indicator of antibiotic drug transfer. 23 
Antibiotic-free whey (negative whey) spiked with different antibiotics was used as a 24 
reference. The antimicrobial activity in whey from milk spiked with most β-lactam 25 
drugs was lower (0-40%) to that of the reference whey, suggesting that these 26 
antibiotics are mostly released from curd and transferred to the whey. However, for 27 
most non-β-lactam drugs, a reduction in the relative antimicrobial activity in whey, 28 
ranging 84 to 100% was obtained, indicating the higher susceptibility for retention in 29 
curd. The traceability of antibiotics through the cheese-making process will make it 30 
possible to determine whether control systems are required to prevent the negative 31 







Antibiotic residues in milk and other foodstuffs of animal origin can lead to negative 35 
implications for consumer health such as allergic reactions or transient disturbances in 36 
the intestinal flora (Demoly & Romano, 2005). Also, the generation of antimicrobial 37 
resistance in microbiota is one of the most important public health problems related to 38 
the excessive use of antibiotics in the treatment of infectious diseases in livestock 39 
(Oliver, Murinda, & Jayarao, 2011; EFSA, 2016).  40 
The processing of contaminated raw milk does not always guarantee the inactivation 41 
or elimination of antibiotic residues and consequently, variable amounts of these 42 
substances might remain in dairy products and with an increased risk for consumers. 43 
Tona and Olusola (2014) indicated the presence of tetracycline residues in soft cheese, 44 
yoghurt and butterfat made from contaminated cow milk. Similarly, Adetunji (2011) 45 
found benzylpenicillin, streptomycin and tetracycline residues in commercial soft 46 
cheese and yoghurt. 47 
Antibiotics could be retained in milk curd to a greater or lesser extent, depending on 48 
the physicochemical properties of these substances and their ability to interact with the 49 
fat and/or protein fraction of the matrix. Sniegocki, Gbylik-Sikorska, & Posyniak 50 
(2015) assessed the potential transfer of chloramphenicol from milk to butter, sour 51 
cream, white cheese and whey using the LC-MS/MS method, observing that this 52 
antibiotic is mainly retained in higher-fat products, such as butter and sour cream, with 53 
lower concentrations in white cheese and whey samples. Berruga, Román, Molina, & 54 
Molina (2005), using the Delvotest SP microbial inhibitor test (DSM Food Specialties, 55 
The Netherlands), found detectable levels of antibiotic residues in whey from 56 





(amoxicillin, ampicillin, benzylpenicillin, cephalexin and ceftiofur) at concentrations 58 
close to their respective maximum residue limits (MRLs). 59 
It should be noted that whey is a by-product of the cheese-making process and is used 60 
in the manufacture of foodstuffs for human consumption, animal feeding and 61 
agricultural applications, among other uses (Carvalho, Prazeres, & Rivas, 2013). 62 
Therefore, the presence of antibiotic residues in whey could have negative 63 
implications for humans, animals and environmental safety. 64 
Current strategies used to minimize the impact of drug residues reaching the food 65 
chain include the routine monitoring of raw milk supplies to detect the presence of 66 
these substances above legally established MRLs (EC, 2010). However, the 67 
monitoring of drug residues in dairy products such as cheeses and whey is not 68 
typically regulated nor have corresponding safety levels been established. 69 
Microbial inhibitor tests are routinely applied in quality control laboratories to screen 70 
for antibiotics in raw milk, as they are relatively inexpensive, easy-to use and have a 71 
broad spectrum of detection (IDF, 2014). The inhibition of microbial growth is a test 72 
in which a positive result is revealed through the use of a dye-type acid-base or redox 73 
indicator which produces a change in the colour of the culture medium, allowing 74 
visual interpretation of test results. Considering the similarity between both matrices 75 
(milk and whey), microbial inhibitor tests could be applied successfully in screening 76 
for antibiotics in whey samples. 77 
In the European Union, two million tons of goat milk are annually produced 78 
(FAOSTAT, 2016) which are traditionally destined for cheese making, often under 79 
quality recognized brands. Studies on the traceability of veterinary drugs during dairy 80 
manufacturing processes are rather limited. However, establishment of the traceability 81 





substances in milk and dairy products. Therefore, the objective of this study was to 83 
assess the susceptibility of different antibiotics to be transferred from milk to whey 84 
during the cheese-making process. 85 
2. Materials and methods 86 
The traceability of antibiotics during an experimental cheese-making process was 87 
evaluated using microbial inhibitor tests for screening of antibiotics in goat milk. The 88 
antimicrobial activity of the whey derived from goat milk spiked with an antibiotic 89 
(Whey from Spiked Milk: WSM) was compared to that of negative goat milk whey 90 
(antibiotic-free whey) spiked with an equivalent concentration of the drug (Whey from 91 
Negative Milk: WNM). Similar antimicrobial activity exhibited in both types of whey 92 
samples (WSM and WNM) will thus indicate that antibiotics added to milk are 93 
completely transferred from the curd to the whey. Lower percentages of positive 94 
results in WSM compared to WNM will thus indicate greater retention of antibiotic in 95 
the curd. 96 
2.1. Whey samples 97 
Whey samples were obtained from a laboratory scale cheese-making process using 98 
raw milk obtained from the experimental flock of Murciano-Granadina goats at 99 
Universitat Politècnica de Valencia (Valencia, Spain). Animals were in mid-lactation 100 
(70-150 days after giving birth), had good health status and did not receive any 101 
veterinary drugs, neither before nor during the experimental period. 102 
Raw goat milk (25 mL), with or without antibiotics, was placed in a tube and heated to 103 
33±1ºC in a thermostatically-controlled water bath. Commercial rennet was used for 104 
coagulation (chymosin>70%, Suministros Arroyo. Santander, Spain) at 0.06% (v/v). 105 
Thirty minutes later, the curd was centrifuged (1026 g, 10 min) for separation of whey 106 





2.2. Antibiotics and spiked samples 108 
Eighteen veterinary antibiotics were selected for this study. Antibiotics, i.e. 8 β-109 
lactams (amoxicillin, ampicillin, benzylpenicillin, cloxacillin, cefacetrile, cefquinome, 110 
ceftiofur, and cephalexin) and 10 non-β-lactam antibiotics (gentamycin, neomycin, 111 
erythromycin, tylosin, ciprofloxacin, enrofloxacin, sulphadiazine, sulphadimethoxine, 112 
oxytetracycline and tetracycline), were provided by Sigma-Aldrich Quimica, S.A. 113 
(Madrid, Spain), except for cefacetrile, which was not commercially available, and 114 
was kindly provided by Fatro S.p.A. (Bologne, Italy). 115 
For use, antibiotics were dissolved in distilled water (1 mg mL-1) at the time when 116 
analyses were performed. In some cases the use of small amounts (i.e. 2-4 mL) of a 117 
suitable solvent (AcOH 5% for enrofloxacin, EtOH for erythromycin, HCl 0.1N for 118 
ciprofloxacin and tetracycline drugs, and NaOH 0.1N for ceftiofur) was necessary 119 
before adding water. 120 
Spiked milk samples were prepared following ISO/IDF recommendations (ISO/IDF, 121 
2003). Spiked whey samples (WNM) were made as follows: 25 mL of antibiotic-free 122 
whey were spiked with a relatively high antibiotic concentration (C1) and 123 
subsequently, seven antibiotic concentrations were obtained by successive dilutions 124 
with negative whey (Table 1) in order to establish the reference dose-response curve. 125 
Negative whey (no antibiotic) was also included in the analysis as a negative control 126 
(C8). The ranges of concentrations for each antibiotic were selected according to the 127 
sensitivity of the microbial test to detect the substance in whey samples. 128 
For comparison, the whey resulting from coagulation of 25 mL of antibiotic-free milk 129 
spiked with an antibiotic (WSM) was recovered in a volumetric flask after 130 





the same dilution procedure as described above was followed to obtain the dose-132 
response curves of recovered WSM. 133 
2.3. Microbial inhibitor tests 134 
The antimicrobial activity of whey samples was evaluated using the Eclipse 100 test 135 
(Zeulab, Zaragoza, Spain), a microbial inhibitor assay employing Geobacillus 136 
stearothermophilus var calidolactis as a test microorganism and bromocresol purple as 137 
acid-base indicator. For the analysis of whey samples containing quinolones, the 138 
Equinox test (Zeulab), using Escherichia coli bacteria and brilliant black as redox 139 
indicator, was utilized. Both tests were carried out according to the manufacturer 140 
instructions for milk analysis. The interpretation of test results was carried out 141 
independently by three trained technicians visually assessing the colour change of the 142 
culture medium after incubation, and classifying the whey samples as either positive 143 
(Eclipse: purple and Equinox: blue) or negative (Eclipse: yellow and Equinox: orange 144 
brown). 145 
Experimental cheeses were made in triplicate and whey analysis was performed in 146 
twelve replicates, resulting in a total of 36 determinations for each antibiotic 147 
concentration and type of whey considered. 148 
2.4. Statistical analysis 149 
To evaluate the antimicrobial activity in whey samples, a logistic regression model 150 
was applied. Statistical analysis was performed employing the stepwise option of the 151 
logistic procedure of SAS software (version 9.2, 2001; SAS Institute, Inc., Cary, NC, 152 
USA), using the following model: 153 
Lijk= logit [Pijk]= β0+β1Ci+β2Wj+εijk (Eq. 1) 154 
where: Lijk= linear logistic model; [Pijk]= [Pp/(1-Pp)]: the probability of a “positive” 155 





the logistic regression model; Ci= antimicrobial concentration (i= 8); Wj= whey type 157 
as dummy variable (W= 0 for WNM; W= 1 for WSM); εijk= residual error. The 158 
concordance coefficient (SAS, 2001) was applied as a range correlation between the 159 
observed responses and predicted probabilities. 160 
The detection capability (CCβ) of the microbial inhibitor tests was calculated from 161 
logistic regression equations as the antibiotic concentration producing 95% positive 162 
results (ISO/IDF, 2002) in the reference whey (WNM). 163 
To investigate the susceptibility of antibiotic transfer to the whey, positive outcomes 164 
in both types of whey samples were compared at an antibiotic concentration equivalent 165 
to the CCβ of the test (Figure 1). Thus, the potential variation in antimicrobial activity 166 
(AAV) was calculated by using the following mathematical expression: 167 
AAV(%) = ((95–PRj)/95)*100 (Eq. 2) 168 
where: AAV= Antimicrobial Activity Variation in WSM with respect to the WNM; 169 
PRj= positive results in WSM (j= 18) at an equivalent concentration producing 95% 170 
positive results in the WNM. 171 
3. Results and Discussion 172 
Table 2 shows the regression equations used to predict positive results in the microbial 173 
inhibitor tests calculated for the 18 antibiotics included in this study. In general, the 174 
frequency of positive results was positively related to the drug concentration present in 175 
the whey samples (β1>0). However, positive outcomes decreased in whey samples 176 
obtained from goat`s milk spiked with most antibiotics tested (β2<0). These results 177 
indicate that the cheese-making processes of milk coagulation and curd draining 178 
significantly affects (p<0.05) the antimicrobial activity of the recovered whey, being 179 






The CCβs of the microbial screening tests calculated in cheese whey are summarized 182 
in Table 2. In general, CCβ values were similar to those reported by other authors for 183 
the Eclipse 100 test in raw goat milk (Beltrán et al., 2015), and by the manufacturer 184 
(Zeulab) for the Equinox test in raw cow milk, suggesting that they could be 185 
successfully applied to detect a great variety of substances in this by-product. 186 
Regarding the susceptibility of antibiotics transferred from milk to whey, Figure 2 187 
summarizes the variation of antimicrobial activity (AAV) in WSM with β-lactam 188 
antibiotics. No antimicrobial activity reduction (AAV= 0%) was found for amoxicillin 189 
and ampicillin, suggesting that almost all of these antibiotics are released from cheese 190 
curd during the draining process. For the rest of the penicillins and for cephalosporins, 191 
a moderate antimicrobial activity reduction ranging from 16 to 40% was demonstrated, 192 
except for cephalexin which presented the highest reduction, around 90%, indicating a 193 
greater likelihood of this antibiotic to be retained in the curd. 194 
The high transfer rate of β-lactam antibiotics from milk to whey could be due to the 195 
water soluble nature of these substances (Rang, Dale, & Ritter, 2000). However, the 196 
lower presence of cephalexin in whey samples could be related to the low solubility in 197 
water of the hydrated molecule used in this study (NCBI, 2016) suggesting that almost 198 
none of this antibiotic is transferred to the whey. 199 
Results obtained for penicillins and cephalosporins are in agreement with those 200 
reported by Berruga, Román, Molina, & Molina (2005) in whey from ewe milk spiked 201 
with β-lactam antibiotics. These results could also explain the lower benzylpenicillin 202 
concentration (5.4±0.1 µg kg-1) reported by Adetunji (2011) in soft cheeses made from 203 





For most non-β-lactam antibiotics, the frequencies of positive results in microbial tests 205 
decreased a great deal in WSM (Figure 2). However, similar antimicrobial activity 206 
values were obtained for both types of whey only in the case of sulphadiazine.  207 
As can be appreciated in Figure 2, the quinolone, aminoglycoside and tetracycline 208 
families presented the highest relative antimicrobial activity reduction. Thus, for 209 
enrofloxacin and ciprofloxacin, AAV were 100%, and ranging from 84 to 100% for 210 
aminoglycosides and tetracyclines. 211 
The susceptibility of quinolones and tetracyclines for retention in the curd after whey 212 
draining could be related to their high fat-solubility. Moreover, tetracyclines might 213 
form metal ion complexes with calcium in casein micelles, which would decrease their 214 
solubility in water (Rang, Dale, & Ritter, 2000). Thus, despite the curd draining 215 
process of cheese-making procedure, similar amounts of tetracycline residues were 216 
reported by Adetunji (2011) in contaminated cow milk (2.7±0.6 µg kg-1) and soft 217 
cheeses made from it (2.1±0.1 µg kg-1). In the case of gentamicin and neomycin, 218 
although aminoglycosides are soluble in water (Drugbank, 2016), results herein 219 
suggest that these substances are largely retained in the curd. 220 
For macrolides and sulphonamides, the AAV calculated for the two substances 221 
considered in each antibiotic family was highly variable, while tylosin, hardly soluble 222 
in water, was retained in the curd (AAV= 96 %), and erythromycin, much more 223 
soluble in water, was mainly released into the whey (AAV below 30 %). Regarding 224 
sulphonamides, which have low solubility in water, differences found in AAV in 225 
WSM with sulphadiazine (0%) and sulphadimethoxine (100%) could be related to the 226 
partition coefficient value being much higher for sulphadimethoxine (log P= 1.63 vs 227 
log P= 0.25) (Drugbank, 2016), indicating a more lipophilic character and therefore 228 






In summary, results herein suggest that the manufacture of cheese made from goat 231 
milk containing antibiotics will result in drug residues in the cheese and in resulting 232 
whey which could compromise the utilization of this by-product, and potentially affect 233 
consumer safety. Antibiotics are transferred from milk to whey to a greater or lesser 234 
extent depending essentially on their physicochemical properties. Thus, Β-lactam 235 
antibiotics, except cephalexin, are mostly transferred from goat milk to whey, while 236 
aminoglycosides, quinolones and tetracyclines present a higher susceptibility for 237 
retention in cheese curd. The transfer rate for antibiotics belonging to macrolides and 238 
sulphonamides are highly variable.  239 
Besides the physicochemical properties of antibiotics, other factors such as milk 240 
composition and specific steps in the cheese-making process, might also affect the 241 
curd retention/whey loss of these substances. Studies on the traceability of veterinary 242 
drugs during dairy manufacturing processes are rather limited. Therefore, performing 243 
similar studies at pilot-scale using HPLC analysis to quantify antibiotic residues is 244 
recommended in order to establish the effects of milk composition and cheese-making 245 
process steps on curd retention and whey recovery of antibiotics. 246 
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Fig. 1. Calculation of the antimicrobial activity variation (AAV %) by comparing the 
dose-response curves (positive results %) obtained for the reference whey (spiked 
Whey from Negative goat Milk: WNM) and for the Whey from Spiked goat Milk 
(WSM). 
 
Fig. 2. Antimicrobial activity variation (AAV %) as indicator of the antibiotic drug 
transfer from goat milk to cheese whey (AAV= 0%, total transfer; AAV= 100%, no 
transfer) 
 
